» Related Searches: breast cancer, drug, prostate cancer, cancer risk, lung cancer
Results 1 to 10 of 68 
FDA OKs Genentech drug for early breast cancer
LOS ANGELES (Reuters) - The U.S. Food and Drug Administration has agreed to expand
the use of Genentech Inc.'s breast cancer drug Herceptin to include women with
early-stage cancer who … 
Dendreon completes FDA filing for prostate-cancer drug
Dendreon said Monday it has submitted the final portion of its application to the Food and
Drug Administration for approval to market its prostate cancer drug in the U.S …
- ├ Dendreon Asks FDA to OK Prostate Drug — Government/ Industry Regulation News from StratCenter.com …
- ├ Dendreon Completes Submission of Biologics License Application … — Government/ Industry Regulation News from StratCenter.com …
- ├ Aeterna prostate cancer drug shows promise — Pharmaceutical Business Review Latest News
- └ all 10 related »
Dismay over cancer drug guidance
Campaigners express dismay that a lung cancer drug available in Scotland will not be
approved for England …
- ├ Cancer drug guidance dismay — BBC News | UK News | England | World Edition
- ├ Cancer drug guidance concern — BBC News | Health | UK Edition
- ├ Watchdog rules against new treatment for lung … — Guardian Unlimited UK Latest
- └ all 10 related »
Anti-cancer drug shows early promise in pulmonary hypertension
A drug used to treat kidney cancer can prevent the development of pulmonary
hypertension in rodents. There is no curative therapy for this condition …
- ├ Recurrent breast cancer: Drug shows promise — The Cancer Blog
- ├ Pulmonary Hypertension and COPD — Medscape Pulmonary Medicine Headlines
- ├ Drug That Interrupts A Key Stage Of … — Health News from Medical News Today
- └ all 10 related »
Lung cancer drug more effective in Taiwanese patients
Filed under: Drug, Lung Cancer, Research, Daily news The lung cancer drug
Gefitinib has been taken off shelves in the United States due to ineffectiveness. But it
remains effective in …
Drug switch 'aids some breast cancer victims'
Women with early-stage, hormone-sensitive breast cancer are significantly more likely
to beat the disease if they switch to a new drug, according to research to be
published today …
FDA Expands Use of Herceptin for Early Stage Breast Cancer …
The new indication is for Herceptin, in combination with other cancer drugs, for the
treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy) …
Synta drug placed on fast track
Synta Pharmaceuticals Corp. said Wednesday that its drug candidate to treat a serious
type of skin cancer has been granted Fast Track designation by the U.S. Food and
Drug Administration …
Drug Might Squeeze Out Bone Cancer
THURSDAY, Nov. 16 (HealthDay News) -- An experimental drug prevented bone tumors in
50 percent of mice in a preclinical study, researchers report …
NICE disapproves the use of cancer drug Tarceva
… cancer, has caused an uproar among the cancer specialists and thousands of
lung cancer patients all over England …
- ├ NICE rejects use of cancer drug Tarceva — Pharmaceutical Business Review Latest News
- ├ NICE consults on advice on two treatments … — OnMedica Latest News
- ├ NICE refuse to fund life-prolonging cancer drug … — the Mail online | Health
- └ all 10 related »